Skip to main content

ORKA (beta)

Oxford Health Research & Knowledge Archive

Archive

GRIN2A (NR2A): a gene contributing to glutamatergic involvement in schizophrenia

Contributors:

Subjects: ,

Cognitive Remediation in Bipolar (CRiB2): study protocol for a randomised controlled trial assessing efficacy and mechanisms of cognitive remediation therapy compared to treatment as usual

Contributors: ; ;

Subjects:

Acute blood biomarker profiles predict cognitive deficits 6 and 12 months after COVID-19 hospitalization

Contributors: ; ;

Subjects: ,

Incidence of Epilepsy and Seizures Over the First 6 Months After a COVID-19 Diagnosis

Contributors: ;

Subjects: ,

CACNA1C (CaV1.2) and other L-type calcium channels in the pathophysiology and treatment of psychiatric disorders: Advances from functional genomics and pharmacoepidemiology

Contributors: ; ; ;

Subjects: ,

Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients

Contributors: ;

Subjects: ,

New drug targets in psychiatry: Neurobiological considerations in the genomics era

Contributors: ; ;

Subjects: ,

Characterizing Affective Variability in Bipolar Disorder and Borderline Personality Disorder, and the Effects of Lithium, Using a Generative Model of Affect

Contributors: ; ; ; ; ;

Subjects: , ,

Exposure to phenytoin associates with a lower risk of post-COVID cognitive deficits: a cohort study

Contributors: ;

Subjects: , ,

Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19

Contributors: ; ;

Subjects: ,